Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women

Molecular and Cellular Biochemistry

Volumn 353, Issue 1-2, 2011, Pages 159-165

  Al Tahhan, Magdy A ^a   Etewa, Rasha L ^a   El Behery, Manal M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

C 511T polymorphism; Cervical cancer; Interleukin 1 gene

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION RESTRICTION FRAGMENT LENGTH POLYMORPHISM; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

ADULT; AGED; CASE-CONTROL STUDIES; EGYPT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79959226286     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0782-9     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
2. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638
3. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350
4. Kang S, Kim JW, Park NH, Song YS, Park YP, Kang SB, Lee HP (2007) Interleukin-1Beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 22:110-113
5. Singh H, Sachan R, Goel H, Mittal B (2008) Genetic variants of interleukin-1RN and interleukin-1b genes and risk of cervical cancer. BJOG 115:633-638 (Pubitemid 351357571)
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867 (Pubitemid 36019639)
7. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M (2001) An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10:1021-1027 (Pubitemid 32959148)
8. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604-1613 (Pubitemid 35378725)
9. Schwebke JR, Zajackowski ME (1997) Effect of concurrent lower genital tract infections on cervical cancer screening. Genitourin Med 73:383-386 (Pubitemid 27479590)
10. Bird S, Zou J, Wang T, Munday B, Cunningham C, Secombes CJ (2002) Evolution of interleukin-1beta. Cytokine Growth Factor Rev 13:483-502
11. Sehouli J, Mustea A, Koensgen D, Chen FCK, Lichtenegger W (2003) Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer. Ann Oncol 14:1501-1504 (Pubitemid 37304604)
12. Sobti RC, Kordi Tamandani DM, Shekari M, Kaur P, Malekzadeh K, Suri V (2008) Interleukin 1 beta gene polymorphism and risk of cervical cancer. Int J Gynaecol Obstet 101:47-52
13. Smith DE, Renshaw BR, Ketchem RR, Garka KE, Sims JE (2000) Four new members expand the interleukin-1 superfamily. J Biol Chem 275:1169-1175 (Pubitemid 30051168)
14. di Giovine FS, Takhsh S, Blakemore AI, Duff GW (1992) Single base polymorphism at-511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1:450-453
15. Gore EA, Sanders JJ, Pandey JP, Palesch Y, Galbraith GM (1998) Interleukin-1beta +3953 allele 2: Association with disease status in adult periodontitis. J Clin Periodontol 25:781-785 (Pubitemid 128705980)
16. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50:1976-1983 (Pubitemid 38725110)
17. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402 (Pubitemid 30164342)
18. Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, Rhee JC, Song SY, Sohn TS (2004) Novel interleukin 1 beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol 39:429-433 (Pubitemid 38811725)
19. Liu J, Zhai X, Jin G, Hu Z, Wang S, Wang X, Qin J, Gao J, Ma H, Wang X, Wei Q, Shen H (2006) Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int J Cancer 118:2554-2558
20. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A (2004) Polymorphisms of the interleukin-1beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109:353-356 (Pubitemid 38252762)
21. Achyut BR, Srivastava A, Bhattacharya S, Mittal B (2007) Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 377:163-169 (Pubitemid 44908245)
22. Qian N, Chen X, Han S, Qiang F, Jin G, Zhou X, Dong J, Wang X, Shen H, Hu X (2010) Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J Cancer Res Clin Oncol 136:709-716
23. Tjiong MY, van der Vange N, ter Schegget JS, Burger MP, ten Kate FW, Out TA (2001) Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14:357-360 (Pubitemid 32730478)
24. Behbakht K, Friedman J, Heimler I, Aroutcheva A, Simoes J, Faro S (2002) Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a casecontrol study. Infect Dis Obstet Gynecol 10:181-186 (Pubitemid 36207209)
25. Majeed GS, Glew S, Bidwell J (1999) An association between LSIL and the high secretor phenotype of IL-1beta. Gynecol Oncol 73:359-361 (Pubitemid 29272855)
26. Stanczuk GA, Sibanda EN, Perrey C, Chirara M, Pravica V, Hutchinson IV, Tswana SA (2001) Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 94:792-794 (Pubitemid 33032825)
27. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM (2005) TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 191:969-976 (Pubitemid 40349814)
28. Thomas M, Pim D, Banks L (1999) The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18:7690-7700 (Pubitemid 30052696)
29. Fu L, VanDoorslaer K, Chen Z, RistrianiT,Masson M, Travé G,Burk RD (2010) Degradation of p53 by human alpha papillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS ONE 5(9):e12816. doi:10.1371/journal.pone.0012816
30. Asschert JG, Vellenga E, Hollema H, van der Zee AG, de Vries EG (1997) Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), interleukin-11 (IL-11) and tumour necrosis factor-alpha (TNF-alpha) in p53-characterised human ovarian carcinomas. Eur J Cancer 33:2246-2251
31. Hybertson BM, Lee YM, Cho HG, Cho OJ, Repine JE (2000) Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally. Inflammation 24:289-293
32. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60:184-190 (Pubitemid 30058750)
33. Simonart T, Van Vooren JP (2002) Interleukin-1beta increases the BCL- 2/BAX ratio in Kaposi's sarcoma cells. Cytokine 19:259-266 (Pubitemid 35352165)
34. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y (2006) Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12:776-779 (Pubitemid 43380763)
35. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, Dong SH, Kim HJ, Kim HB, Lee JI, Chang R (2005) Interleukin-1β (IL-1β) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 114:465-471
36. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW (2006) Single nucleotide polymorphisms in the human interleukin-1β gene affect transcription according to haplotype context. Hum Mol Genet 15:519-529 (Pubitemid 43205418)